Search results for: Health Care Systems

2015 OHE Annual Lecture: Regulation, Reimbursement, and Evidence on New Medical Technologies: Experiences and Future Directions in the United States

10 June 2015

…reforms to improve health care, including such areas as accountable care, better evidence from real-world practice, and more effective drug and device innovation.   A doctor and economist by training,…

OHE at ISPOR Philadelphia Part 1: MCDA, Utility Functions and Big Data

7 May 2015

…hours: 8:30 AM – 2:15 PM Author discussion: 1:15 PM – 2:15 PM   The ISPOR MCDA task force: How best to use it in health care decision making  …

New Publication: Risk-Sharing Agreements Between Pharmaceutical Manufacturers and Payers

25 September 2015

…health outcomes-based RSAs. The authors explain that utilisation of RSAs could increase as data systems improve and incentives evolve as a result of health reform and accountable care organisations.  Access…

Multi-indication Pricing: Pros, Cons and Applicability to the UK

28 October 2015

…with health care system stakeholders was organised to explore (i) the attractiveness of MIP as a potential solution to the challenge of providing optimal pricing for, and reimbursement of, multi-indication…

How to Manage Data Governance in an Era of Real World Evidence (RWE): Working Towards a Set of International Standards

24 November 2015

…that is becoming increasingly widespread in health economics and health services research – with good reason. RWD is information that can be used for health care decision-making which is collected…

New Publication: Headroom Approach to Device Development

23 February 2016

…2014. Are the UK systems of innovation and evaluation of medical devices compatible? The role of NICE’s medical technologies evaluation programme (MTEP). Applied Health Economics and Health Policy, 12(4), pp.347-357….

Economics of Innovation

…design. Our work encompasses the perspectives of patients, industry, investors, payers, healthcare system decision makers, and policymakers.  We maintain a global outlook, recognising that the health technology industry is international and…

The Dynamics of Drug Shortages

9 January 2024

…include higher out-of-pocket payments for patients as well as more resources being diverted to controlling shortages rather than other healthcare resource utilisation. Recommendations Governments around the world have been working…

New Methods for Modelling EQ-5D-5L Value Sets: An Application to English Data

1 January 2016

…in Health Economics. There are some differences between the value set reported in the Health Economics version and the provisional value set reported in the OHE Research Paper version. Any…